J&J Medical Connect
ICOTYDE®

(icotrokinra)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

ICOTYDE® (icotrokinra)
Medical Information

ICOTYDE - Missed Doses

Last Updated: 10/15/2026

SUMMARY

  • The company cannot recommend any practices, procedures or usage of ICOTYDE (icotrokinra) that deviate from the approved labeling.
  • Please refer to the icotrokinra local labeling for additional details on dosage and administration.

CompanY COre Data SHeet

Missed Dose

  • If a patient misses a dose, instruct the patient to take the missed dose as soon as possible with a return to normal dosing schedule the following day.1

LITERATURE SEARCH

A literature search of MEDLINE®, EMBASE®, BIOSIS Previews®, and DERWENT® (and/or other resources, including internal/external databases) was conducted on 24 August 2026.

 

References

Show
1 Data on File. Icotrokinra. Company Core Data Sheet v002. Janssen Research & Development, LLC. EDMS-RIM-1387700; 2026.  

Would you like to clear and leave your conversation? Message history will be lost.